User profiles for "author:Koji Abe"
Koji AbeStanford University Verified email at stanford.edu Cited by 1339 |
Interactions between macromolecules in solution and intermacromolecular complexes
E Tsuchida, K Abe - Interactions between macromolecules in solution and …, 2005 - Springer
Macromolecules with complementary binding sites associate almost stoichiometrically in
solution to form the “intermacromolecular complex”. Studies on intermacromolecular …
solution to form the “intermacromolecular complex”. Studies on intermacromolecular …
Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury
K Abe - Journal of Cerebral Blood Flow & Metabolism, 2000 - journals.sagepub.com
Development of neuronal and glial cells and their maintenance are under control of
neurotrophic factors (NTFs). An exogenous administration of NTFs protects extremely …
neurotrophic factors (NTFs). An exogenous administration of NTFs protects extremely …
Inkjet-printed microfluidic multianalyte chemical sensing paper
This paper presents an inkjet printing method for the fabrication of entire microfluidic
multianalyte chemical sensing devices made from paper suitable for quantitative analysis …
multianalyte chemical sensing devices made from paper suitable for quantitative analysis …
Stem cell therapy for cerebral ischemia: from basic science to clinical applications
K Abe, T Yamashita, S Takizawa… - Journal of Cerebral …, 2012 - journals.sagepub.com
Recent stem cell technology provides a strong therapeutic potential not only for acute
ischemic stroke but also for chronic progressive neurodegenerative diseases such as …
ischemic stroke but also for chronic progressive neurodegenerative diseases such as …
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
K Abe, M Aoki, S Tsuji, Y Itoyama, G Sobue… - The Lancet …, 2017 - thelancet.com
Background In a previous phase 3 study in patients with amyotrophic lateral sclerosis (ALS),
edaravone did not show a significant difference in the Revised ALS Functional Rating Scale …
edaravone did not show a significant difference in the Revised ALS Functional Rating Scale …
Mutations of optineurin in amyotrophic lateral sclerosis
H Maruyama, H Morino, H Ito, Y Izumi, H Kato… - Nature, 2010 - nature.com
Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder
characterized by degeneration of motor neurons of the primary motor cortex, brainstem and …
characterized by degeneration of motor neurons of the primary motor cortex, brainstem and …
Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum
T Yamashita, M Ninomiya, PH Acosta… - Journal of …, 2006 - Soc Neuroscience
Recent studies have revealed that the adult mammalian brain has the capacity to regenerate
some neurons after various insults. However, the precise mechanism of insult-induced …
some neurons after various insults. However, the precise mechanism of insult-induced …
Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.
K Abe, S Yuki, K Kogure - Stroke, 1988 - Am Heart Assoc
Regional changes in the amount of free fatty acids, polyphosphoinositides, and water
content in the cerebral cortex were examined using a middle cerebral artery occlusion …
content in the cerebral cortex were examined using a middle cerebral artery occlusion …
Inkjet-printed paperfluidic immuno-chemical sensing device
K Abe, K Kotera, K Suzuki, D Citterio - Analytical and bioanalytical …, 2010 - Springer
This paper reports on an inkjet printing method for the fabrication of lateral flow
immunochromatographic devices made from a single piece of filter paper by patterning …
immunochromatographic devices made from a single piece of filter paper by patterning …
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
K Abe, Y Itoyama, G Sobue, S Tsuji, M Aoki… - … Lateral Sclerosis and …, 2014 - Taylor & Francis
Our objective was to confirm the efficacy and safety of edaravone in amyotrophic lateral
sclerosis (ALS) patients. We conducted a 36-week confirmatory study, consisting of 12-week …
sclerosis (ALS) patients. We conducted a 36-week confirmatory study, consisting of 12-week …